Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.17B |
| 2 |
Microsoft
MSFT
|
+$619M |
| 3 |
Apple
AAPL
|
+$377M |
| 4 |
Booking.com
BKNG
|
+$319M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.48B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$896M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$599M |
| 4 |
Citigroup
C
|
+$467M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.29% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.55% |
| 4 | Financials | 1.15% |
| 5 | Healthcare | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
ProShares UltraPro Dow 30
UDOW
$872M
| $4.27M | ﹤0.01% |
150,492
+60,726
| +68% | +$1.67M |
|
3427
CALL
Anavex Life Sciences
AVXL
$277M
| $4.27M | ﹤0.01% |
460,700
-60,100
| -12% | -$642K |
|
3428
B2Gold
BTG
$7.48B
| $4.27M | ﹤0.01% |
1,194,914
+23,180
| +2% | +$77.1K |
|
3429
Globalstar
GSAT
$10.6B
| $4.26M | ﹤0.01% |
213,607
-61,778
| -22% | -$1.62M |
|
3430
PUT
Sundial Growers
SNDL
$336M
| $4.26M | ﹤0.01% |
2,036,300
-2,410,900
| -54% | -$5.74M |
|
3431
CALL
Under Armour
UAA
$2.18B
| $4.25M | ﹤0.01% |
418,600
+258,500
| +161% | +$2.24M |
|
3432
CALL
Neurocrine Biosciences
NBIX
$15.7B
| $4.25M | ﹤0.01% |
35,600
-28,200
| -44% | -$3.3M |
|
3433
PUT
USA Compression Partners
USAC
$3.9B
| $4.25M | ﹤0.01% |
217,600
+45,100
| +26% | +$832K |
|
3434
First Trust Natural Gas ETF
FCG
$669M
| $4.25M | ﹤0.01% |
173,356
+7,590
| +5% | +$198K |
|
3435
PennyMac Financial
PFSI
$3.81B
| $4.24M | ﹤0.01% |
74,850
-6,155
| -8% | -$326K |
|
3436
CALL
CenterPoint Energy
CNP
$25.8B
| $4.24M | ﹤0.01% |
141,400
-146,000
| -51% | -$4.25M |
|
3437
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.58B
| $4.24M | ﹤0.01% |
84,731
-208,168
| -71% | -$10.4M |
|
3438
CALL
National Beverage
FIZZ
$3.05B
| $4.23M | ﹤0.01% |
91,000
-26,100
| -22% | -$1.22M |
|
3439
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.55B
| $4.23M | ﹤0.01% |
46,795
-101,705
| -68% | -$9.15M |
|
3440
United States Natural Gas Fund
UNG
$520M
| $4.23M | ﹤0.01% |
75,000
+49,663
| +196% | +$3.95M |
|
|
SAGE
3441
CALL
DELISTED
Sage Therapeutics
SAGE
| $4.23M | ﹤0.01% |
110,800
-39,300
| -26% | -$1.5M |
|
3442
CALL
Invesco CurrencyShares Canadian Dollar Trust
FXC
$66.9M
| $4.22M | ﹤0.01% |
58,400
-52,100
| -47% | -$3.75M |
|
|
ARNC
3443
CALL
DELISTED
Arconic Corporation
ARNC
| $4.22M | ﹤0.01% |
199,300
+30,400
| +18% | +$636K |
|
3444
Invesco Energy Exploration & Production ETF
PXE
$86.3M
| $4.21M | ﹤0.01% |
142,418
+133,367
| +1,474% | +$4.24M |
|
3445
Calumet Specialty Products
CLMT
$4.2B
| $4.21M | ﹤0.01% |
249,339
-305,227
| -55% | -$4.92M |
|
|
ODP
3446
CALL
DELISTED
ODP
ODP
| $4.21M | ﹤0.01% |
92,400
+61,000
| +194% | +$2.6M |
|
3447
PUT
Concentrix
CNXC
$1.79B
| $4.21M | ﹤0.01% |
31,600
-86,600
| -73% | -$10.5M |
|
3448
Nordic American Tanker
NAT
$1.43B
| $4.21M | ﹤0.01% |
1,374,754
+393,069
| +40% | +$1.27M |
|
|
DQ
3449
PUT
Daqo New Energy
DQ
$926M
| $4.2M | ﹤0.01% |
108,900
-183,700
| -63% | -$8.99M |
|
|
MYOV
3450
CALL
DELISTED
Myovant Sciences Ltd.
MYOV
| $4.2M | ﹤0.01% |
155,900
-7,500
| -5% | -$197K |
|
Similar funds
Jeff Yass's Q4 2022 Portfolio in Review
As of Q4 2022, Jeff Yass held 14,748 positions worth $395B, up 2.2% from $387B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q4 2022 filing shows 1,670 new, 4,598 increased, 5,764 reduced and 2,486 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M. The largest sale was Amazon, an estimated $1.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2022 buy was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M.
- Jeff Yass added most to Tesla in Q4 2022, an estimated $2.17B increase.
- Jeff Yass's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.48B.
- Jeff Yass fully exited Twitter, Inc. in Q4 2022, selling an estimated $76M.
- Jeff Yass's ten largest holdings make up 27% of its $395B portfolio in Q4 2022.
- Jeff Yass opened 1,670 new positions and closed 2,486 in Q4 2022.
- Jeff Yass's portfolio value rose 2.2% quarter-over-quarter to $395B.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.